Home/Filings/4/0001567619-19-005295
4//SEC Filing

Carter Michael Collier 4

Accession 0001567619-19-005295

CIK 0001444380other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 6:27 PM ET

Size

16.6 KB

Accession

0001567619-19-005295

Insider Transaction Report

Form 4
Period: 2019-02-20
Carter Michael Collier
Vice President, Sales
Transactions
  • Award

    Common Stock

    2019-02-20+39,35039,350 total
  • Award

    Stock Option (Right to Buy)

    2019-02-20+78,70078,700 total
    Exercise: $48.44Exp: 2029-02-19Common Stock (78,700 underlying)
Footnotes (2)
  • [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually on March 5 of each year, beginning March 5, 2020, subject to the Reporting Person's continued service.
  • [F2]25% of the shares subject to the option vest on the first anniversary measured from February 20, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Issuer

NEVRO CORP

CIK 0001444380

Entity typeother

Related Parties

1
  • filerCIK 0001768792

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 6:27 PM ET
Size
16.6 KB